The Global Virus Network (GVN) was established in 2011 to strengthen research and responses to emerging viral causes of human disease and to prepare against new viral pandemics. There are now 40 GVN Centers of Excellence and 6 Affiliate laboratories in 24 countries. The 2017 meeting was held from September 25–27 in Melbourne, Australia, and was hosted by the Peter Doherty Institute for Infection and Immunity and the Institut Pasteur. This report highlights the recent accomplishments of GVN researchers in several important areas of medical virology, including the recent Zika epidemic, infections by human papillomavirus, influenza, HIV, hepatitis C, HTLV-1, and chikungunya viruses, and new and emerging viruses in the Australasia region. Plans for the 2018 meeting also are noted.

全球病毒网络（GVN）成立于2011年，旨在加强对新兴的人类疾病病毒原因的研究和应对，并为应对新的病毒性大流行做好准备。现在，在24个国家/地区拥有40个GVN卓越中心和6个会员实验室。2017年会议于9月25日至27日在澳大利亚墨尔本举行，由彼得·多尔蒂感染与免疫研究所和巴斯德研究所主办。本报告重点介绍了GVN研究人员在医学病毒学几个重要领域的最新成就，包括最近的寨卡流行，人类乳头瘤病毒，流感，HIV，丙型肝炎，HTLV-1和基孔肯雅病毒的感染，以及新出现的病毒。大洋洲地区。还指出了2018年会议的计划。